Source: Kapitales Research

Highlights

• The initial production module is expected to manufacture up to 20 kilograms of enriched silicon-28 annually, subject to customer requirements and market demand.
• Silex expects the global market for quantum-grade silicon to expand significantly over the next five to ten years, creating opportunities for future production growth.
• Construction of the pioneering laser-based Quantum Silicon (Q-Si) Production Plant has been successfully completed, with commissioning activities currently in progress ahead of production.

Commissioning Begins After Construction Milestone

Silex Systems Limited (ASX: SLX) traded at a CMP of AU$5.290 after declining 1.5% as investors assessed the company's latest operational milestone. The technology developer has completed construction of its Quantum Silicon (Q-Si) Production Plant in Sydney, believed to be the world's first laser-based silicon enrichment facility. With construction now finished, the company has entered the commissioning stage, bringing it one step closer to supplying enriched silicon-28 for the rapidly evolving quantum computing industry.

Current commissioning work involves integrating the advanced laser system with the plant's first two silicon enrichment reactors before final testing later this year. Management expects sample production of highly enriched silicon-28 to commence during the first quarter of calendar year 2027, representing an important step towards commercial operations.

Growing Demand Could Unlock Long-Term Opportunity

Silicon-28 is a specialised material used to manufacture qubits, the fundamental building blocks of silicon-based quantum computers. As technology companies continue investing heavily in quantum computing, demand for ultra-high-purity silicon is expected to strengthen. Silex aims to establish itself as a strategic Western supplier of this critical material, providing an alternative to traditional overseas sources.

The plant's first production module is designed to produce up to 20 kilograms annually, although output will depend on customer purity requirements and demand. According to the company's internal assessment, the current global market remains below 50 kilograms per year, but management expects demand to increase substantially over the next five to ten years as commercial adoption of quantum computing accelerates.

Commercial Progress Remains in Focus

Silex has already secured its first commercial offtake partner, Silicon Quantum Computing Pty Ltd, and is working to qualify its Quantum Silicon products for customer use. At the same time, discussions with additional international customers continue, with management targeting further supply agreements over the coming year. The company has also indicated that modular production capacity could be expanded at a dedicated site as market demand grows.

Will This Be the Turning Point?

Completing construction marks a significant achievement, but the next phase could prove even more important. Investors will be closely monitoring the commissioning process, the commencement of sample production in 2027 and the company's ability to secure additional commercial customers. If these milestones are successfully delivered, they could determine whether Silex transforms its technological leadership into sustained commercial growth and renewed momentum for the stock.

Note- All data presented is based on information available at the time of writing.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au